What investors learned from the Elizabeth Holmes trial: ‘zero’


While the guilty verdict for Theranos founder Elizabeth Holmes may not change how venture capital fundraising works, it may have an impact on other women founders, say industry players. — AFP

It took a jury seven full days to conclude that Theranos Inc. founder Elizabeth Holmes was guilty of four counts of fraud after a three-month trial. The startup world had been watching in suspense, but it was largely for the spectacle of it all – not because anyone thought the verdict would significantly change behaviour in venture capital fundraising.

Holmes was convicted of defrauding investors in the blood-testing startup of hundreds of millions of dollars, which should spur investors to scrutinise their portfolio companies more carefully, especially in the specialised world of healthcare.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In Tech News

Atos considers sale of additional assets
Intravenous education: China hospitals set up ‘classrooms’ so sick children can study during nationwide outbreak of respiratory diseases, earns online backlash
How China is using the law to tackle cyberbullying and Internet violence
‘I have a home now’: China DNA match sees repentant petty criminal abducted as child reunited with parents 33 years on
Chinese scientists achieve breakthrough in early detection of ‘king cancer’ that killed Steve Jobs
Some Google Drive users are reporting that their files have disappeared. Are you affected?
TNG says its RFID tags don’t have an expiry date after promo for pilot users goes viral
Cryptoverse: 'Layer two' tokens enjoy new life as bitcoin soars
Meta Platforms' paid ad-free service targeted in Austrian privacy complaint
Opinion: Companies’ deceptive ‘dark patterns’ online cost you money – here’s how to fight back

Others Also Read